JPRN-jRCT2080223060已完成1 期
Safety study of NaPPS in pediatric patients with mucopolysaccharidosis type VI
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 2
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 6age old 至 <= 14age old（—）
- 性别
- All
入选标准
- •(1) Patients who are confirmly diagnosed with Mucopolysaccharidosis type VI and have assessable symptoms of cartilage and bone.
- •(2) Patients who are able to explain their own condition or to show their own intention.
- •(3) Patients who are able to walk for 6 minutes continuously.
排除标准
- 未提供
研究者
相似试验
尚未招募
3 期
Assessment of praziquantel medication for children living in areas where schistosomiasis is common in Bahia and SergipeRBR-86kcy37Instituto Gonçalo Moniz (IGM) - Fundação Oswaldo Cruz (Fiocruz-BA)
尚未招募
1 期
euroEPO-Stroke. Phase I-IIStrokeRPCEC00000185Center of Molecular Immunology, CIMAB
招募中
不适用
Study on the safety and clinical significance of preoperative oral rehydration therapyElective surgery patientsJPRN-UMIN000007778Kumamoto University Hospital80
已完成
不适用
Clinical evaluation of the effects of paediatric dental general anaesthesia and midazolam sedation on cognitive function, anxiety and access to future dental careDental caries requiring multiple extractionsOral HealthCariesISRCTN12026431Scottish Executive Chief Scientist Office (UK)200
已完成
不适用
Prospective clinical study in children with severe haemophilia A to investigate clinical efficacy, immunogenicity, pharmacokinetics, and safety of Human-cl rhFVIIISevere haemophilia AHaematological DisordersHaemophiliaISRCTN71212110Octapharma AG (Switzerland)60